Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L. Geyer, Peihong Zhang, Gabriel Étienne et al.|Haematologica|2016Cited by 73
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly L. Geyer, Jan Samuelsson, Robyn M. Scherber et al.|Journal of Clinical Oncology|2015Cited by 65
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H. Scotch, Robert Peter Gale, Heidi Kosiorek et al.|Leukemia Research|2017Cited by 27
CALR mutation screening in pediatric primary myelofibrosisWenbin An, Xiaofan Zhu, Yang Wan et al.|Pediatric Blood & Cancer|2014Cited by 25
OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 StudyYi-Kan Cheng, Yong Song, Yun Fan et al.|Journal of Thoracic Oncology|2023Cited by 23